Current development in the formulations of non-injection administration of paclitaxel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current development in the formulations of non-injection administration of paclitaxel

Published:2018-05 Issue:1-2 Volume:542 Page:242-252
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Du Xiyou,Khan Abdur Rauf,Fu Manfei,Ji Jianbo,Yu Aihua,Zhai Guangxi^ORCID

Funder

Shandong Province

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference111 articles.

1. Brain targeted delivery of paclitaxel using endogenous ligand;Acharya;Asian J. Pharm. Sci.,2016

2. The effect of HPMC and MC as pore formers on the rheology of the implant microenvironment and the drug release in vitro;Aho;Carbohydr. Polym.,2017

3. Transdermal delivery of dimethyl fumarate for Alzheimer’s disease: effect of penetration enhancers;Ameen;Int. J. Pharm.,2017

4. A theoretical basis for a biopharmaceutic drug classification the correlation of in vitro drug product dissolution and in vitro bioavailability;Amidon;Pharm. Res.,1995

5. Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release;Aryal;Nanomedicine (Lond.),2013

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Folate-Functionalized Magnetic-Gold Nanoparticles Based Targeted Drug Delivery for Liver: In Vitro, In Vivo and Docking Studies;ACS Biomaterials Science & Engineering;2024-09-02

2. WITHDRAWN: Folic acid Grafted, cell-penetrating peptide conjugated pH-sensitive hydrophobically modified Glycol chitosan nanoparticles for drug delivery in breast cancer;Chemical Engineering Journal;2024-07

3. Premix technologies for drug delivery: manufacturing, applications, and opportunities in regulatory filing;Drug Discovery Today;2024-06

4. STUDY ON FORMULATION OF BACTERIAL CELLULOSE NANOFIBERS-COATED NANOLIPOSOMES CONTAINING PACLITAXEL FOR ORAL ADMINISTRATION;International Journal of Applied Pharmaceutics;2024-03-07

5. Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications;Materials Today Bio;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3